590 studies found for:    Open Studies | "Hormones"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hormones"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Conditions: Growth Hormone Deficiency, Pediatric;   hGH (Human Growth Hormone);   Endocrine System Diseases;   Hormones;   Pituitary Diseases
Interventions: Drug: Once weekly subcutaneous injection of TransCon hGH;   Drug: Once daily subcutaneous injection of Genotropin
2 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
3 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
4 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
5 Unknown  Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth hormone
6 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
7 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
8 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
9 Unknown  Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: Fermented Wheat germ extract
10 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
11 Recruiting Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
Condition: Growth Hormone Deficiency With Pituitary Anomalies
Interventions: Drug: Macimorelin;   Drug: Insulin
12 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
13 Recruiting A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Condition: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: Tamoxifen;   Drug: Fulvestrant;   Drug: goserelin
14 Recruiting Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)
Conditions: Endometrial Carcinoma;   Metastatic Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: AZD2014;   Drug: Anastrozole
15 Unknown  Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Conditions: Hormone-Sensitive Breast Cancer;   Breast Cancer
Interventions: Drug: Letrozole;   Drug: Bevacizumab
16 Recruiting Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Conditions: Early-Stage Breast Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin;   Drug: Palbociclib
17 Recruiting Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
18 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
19 Unknown  Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Exemestane;   Drug: Everolimus
20 Recruiting Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Conditions: Breast Neoplasms;   Breast Diseases;   Neoplasms;   Neoplasms by Site;   Fulvestrant;   Antineoplastic Agents;   Antineoplastic Agents, Hormonal;   Estrogen Receptor Antagonists;   Hormone Antagonists;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Molecular Mechanisms of Pharmacological Action;   Pharmacologic Actions;   Therapeutic Use
Interventions: Drug: Ribociclib;   Drug: fulvestrant;   Drug: Ribociclib placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years